A. Nazari Et Al. , "The Effectiveness of 177Lu-DOTA TATE in Radioiodine-Refractory Differentiated Thyroid Cancer," 33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , vol.47, ELECTR NETWORK, 2020
Nazari, A. Et Al. 2020. The Effectiveness of 177Lu-DOTA TATE in Radioiodine-Refractory Differentiated Thyroid Cancer. 33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , (ELECTR NETWORK).
Nazari, A., Sager, M. S., Bilgic, S., Beytur, F., Besli, R. L. U., Asa, S., ... Kabasakal, L.(2020). The Effectiveness of 177Lu-DOTA TATE in Radioiodine-Refractory Differentiated Thyroid Cancer . 33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), ELECTR NETWORK
Nazari, A. Et Al. "The Effectiveness of 177Lu-DOTA TATE in Radioiodine-Refractory Differentiated Thyroid Cancer," 33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM), ELECTR NETWORK, 2020
Nazari, A. Et Al. "The Effectiveness of 177Lu-DOTA TATE in Radioiodine-Refractory Differentiated Thyroid Cancer." 33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , ELECTR NETWORK, 2020
Nazari, A. Et Al. (2020) . "The Effectiveness of 177Lu-DOTA TATE in Radioiodine-Refractory Differentiated Thyroid Cancer." 33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM) , ELECTR NETWORK.
@conferencepaper{conferencepaper, author={A. Nazari Et Al. }, title={The Effectiveness of 177Lu-DOTA TATE in Radioiodine-Refractory Differentiated Thyroid Cancer}, congress name={33rd Annual Congress of the European-Association-of-Nuclear-Medicine (EANM)}, city={}, country={ELECTR NETWORK}, year={2020}}